Application of Different Assessment Methods in Cardiovascular Disease Risk Assessment of T2DM

Peiqi CHEN; Zonglu YANG; Ling ZHAO; Shigang DU; Lu YANG; Shiyu LI; Yuru DAI; Tingyu KE

doi:10.12259/j.issn.2095-610X.S20220406

Volume 43 Issue 4

Apr. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(4): 62-69

Peiqi CHEN, Zonglu YANG, Ling ZHAO, Shigang DU, Lu YANG, Shiyu LI, Yuru DAI, Tingyu KE. Application of Different Assessment Methods in Cardiovascular Disease Risk Assessment of T2DM[J]. Journal of Kunming Medical University, 2022, 43(4): 62-69. doi: 10.12259/j.issn.2095-610X.S20220406

Citation:

Peiqi CHEN, Zonglu YANG, Ling ZHAO, Shigang DU, Lu YANG, Shiyu LI, Yuru DAI, Tingyu KE. Application of Different Assessment Methods in Cardiovascular Disease Risk Assessment of T2DM[J]. Journal of Kunming Medical University, 2022, 43(4): 62-69. doi: 10.12259/j.issn.2095-610X.S20220406

Citation:

Peiqi CHEN, Zonglu YANG, Ling ZHAO, Shigang DU, Lu YANG, Shiyu LI, Yuru DAI, Tingyu KE. Application of Different Assessment Methods in Cardiovascular Disease Risk Assessment of T2DM[J]. Journal of Kunming Medical University, 2022, 43(4): 62-69. doi: 10.12259/j.issn.2095-610X.S20220406

PDF( 794 KB)

Application of Different Assessment Methods in Cardiovascular Disease Risk Assessment of T2DM

doi: 10.12259/j.issn.2095-610X.S20220406

Dept. of Endocrinology，The 2nd Affiliated Hospital of Kunming Medical University， Kunming Yunnan 650101， China

Received Date: 2021-12-01
Publish Date: 2022-04-25

Abstract

Abstract

Objective To analyze the consistency between the Framinghan, the advance-risk scale and the “sugar-heart risk assessment”, the “CV risk assessment” model on the risk of cardiovascular death in T2DM patients in the next 10 years. Methods A retrospective study of 527 inpatients who met the diagnostic criteria for type 2 diabetes in the Department of Endocrinology, The Second Affiliated Hospital of Kunming Medical University from January 2018 to December 2020 was conducted. The Framinghan rating scale and the Cardiovascular risk assessment for diabetes mellitus model were used to assess the occurrence risk of cardiovascular disease over the next 10 years. 148 patients with increased diabetes duration, UACR and other indicators were included. ADVANCE Risk score and CV Risk Assessment project were used to evaluate the risk of cardiovascular death of the same patient in the next 10 years. Kappa values were used to evaluate the consistency of the results of the two methods. Results The result of Cardiovascular risk assessment for diabetes mellitus model: 431 patients （81.78%） in the medium-risk group, and 250 patients （47.44%） in the high-risk group using Framinghan rating scale. SPSS analysis showed Kappa value, K = 0.051, P = 0.001; The result of CV Risk assessment”: 98 patients （66.22%） in the very high Risk group, and 76 patients （50%） in the ADVANCE Risk model. SPSS analysis showed Kappa value, K = 0.492, P = 0.000. Conclusion In this study, the “Cardiovascular risk assessment for diabetes mellitus” model and Framinghan rating scale in assessing the occurrence risk of cardiovascular disease in patients with type 2 diabetes in the next 10 years were very inconsistent. The “CV Risk assessment” and ADVANCE Risk model had moderate consistency in assessing the mortality risk of cardiovascular in patients with type 2 diabetes over the next 10 years.
- Type 2 diabetes,
- Cardiovascular disease,
- Risk assessment

FullText(HTML)

References(20)

References

[1]	Khan M A B,Hashim M J,King J K,et al. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends[J]. J Epidemiol Glob Health,2020,10(1):107-111.
[2]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志,2018,38(4):292-344.
[3]	American Diabetes Association. 9. Cardiovascular disease and risk management: Standards of medical care in diabetes-2018[J]. Diabetes Care, 2018, 41（Suppl 1）: 86-104.
[4]	Grimaldi A,Heurtier A. Critères diagnostiques du diabète de type 2 [Diagnostic criteria for type 2 diabetes][J]. Rev Prat,1999,49(1):16-21.
[5]	Yang X,Li J,Hu D,et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in chinese population:The China-PAR project (prediction for ASCVD risk in China)[J]. Circulation,2016,134(19):1430-1440. doi: 10.1161/CIRCULATIONAHA.116.022367
[6]	Nishimura K,Okamura T,Watanabe M,et al. Predicting coronary heart disease using risk factor categories for a Japanese Urban Population,and comparison with the Framingham risk score:The Suita Study[J]. J Atheroscler Thromb,2016,23(9):1138-1139. doi: 10.5551/jat.Er19356
[7]	Expert Panel on Detection,Evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP)Expert Panel on Detection,Evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III)[J]. JAMA,2001,285(19):2486-2497. doi: 10.1001/jama.285.19.2486
[8]	孙宁玲,施仲伟,霍勇. 高血压合并左心室肥厚诊治专家共识[J]. 中华心血管病杂志(网络版),2019,2(1):5.
[9]	廖二元, 袁凌青, 谢忠建, 等. 内分泌代谢病学[M]. 北京: 人民卫生出版社, 2019: 1571.
[10]	诸骏仁,高润霖,赵水平,等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华健康管理学杂志,2017,11(1):7-28. doi: 10.3760/j.issn.1674-0815.2017.01.003
[11]	中国心血管病预防指南(2017)写作组,中华心血管病杂志编辑委员会. 中国心血管病预防指南(2017)[J]. 中华心血管病杂志,2018,46(01):10-25. doi: 10.3760/cma.j.issn.0253-3758.2018.01.004
[12]	Kengne A P. The ADVANCE cardiovascular risk model and current strategies for cardiovascular disease risk evaluation in people with diabetes[J]. Cardiovasc J Afr,2013,24(9-10):376-381.
[13]	Kengne A P,Patel A,Marre M,et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes[J]. Eur J Cardiovasc Prev Rehabil,2011,18(3):393-398. doi: 10.1177/1741826710394270
[14]	Zheng Y,Ley S H,Hu F B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinol,2018,14(2):88-98. doi: 10.1038/nrendo.2017.151
[15]	De Meyer T,Nawrot T,Bekaert S,et al. Telomere length as cardiovascularagingbiomarker:JACC review topic of the week[J]. J Am Coll Cardiol,2018,72(7):805-813. doi: 10.1016/j.jacc.2018.06.014
[16]	Wada H,Miyauchi K,Daida H. Gender differences in the clinical features and outcomes of patients with coronary artery disease[J]. Expert Rev Cardiovasc Ther,2019,17(2):127-133. doi: 10.1080/14779072.2019.1561277
[17]	Choi Y J,Kim S H,Kang S H,et al. Reconsidering the cut-off diastolic blood pressure for predicting cardiovascular events:A nationwide population-based study from Korea[J]. Eur Heart J,2019,40(9):724-731. doi: 10.1093/eurheartj/ehy801
[18]	Østergaard H B,Mandrup Poulsen T,Berkelmans G F N,et al. Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients[J]. Diabetes Metab,2019,45(3):254-260. doi: 10.1016/j.diabet.2018.04.006
[19]	Cooney M T,Selmer R,Lindman A,et al. Cardiovascular risk estimation in older persons:SCORE O. P[J]. Eur J Prev Cardiol,2016,23(10):1093-1103. doi: 10.1177/2047487315588390
[20]	Brownrigg J R,Hughes C O,Burleigh D,et al. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes:A population-level cohort study[J]. Lancet Diabetes Endocrinol,2016,4(7):588-597. doi: 10.1016/S2213-8587(16)30057-2

Relative Articles(20)

Relative Articles

[1]	Xinlin ZHU, Yanan WU, Qi MENG, Qianzi YANG, Yuanbiao LI, Junheng TAO, Mengyang HE. Influence of Medication Compliance of Type 2 Diabetes Chronic Disease Management Patients in Two Communities of Kunming on Disease Control. Journal of Kunming Medical University, 2024, 45(3): 79-83. doi: 10.12259/j.issn.2095-610X.S20240312
[2]	Fan ZHANG, Weichang GUO, Hong TAN, Hejia YIN, Luping PENG, Yan ZHAO, Huifang LI. Development and Validation of Risk Predicting Model for Severe Diabetic Peripheral Neuropathy Based on Glucose Variability Parameters. Journal of Kunming Medical University, 2023, 44(5): 53-59. doi: 10.12259/j.issn.2095-610X.S20230526
[3]	Yuqing XIE, Jun WANG, Xuebi JI, Ping WANG, Haifeng WANG, Xumin LI, Linya HUANG. Research Progress on Risk Factors and Risk Assessment of Urinary Tract Infection in Patients with Ureterostomy. Journal of Kunming Medical University, 2023, 44(11): 158-163. doi: 10.12259/j.issn.2095-610X.S20231124
[4]	Hong TAN, Hejia YIN, Yan LI, Qin HU, Lan LI, Zundan REN, Rou SHI. Correlation between DDAH1 Gene 836A/T Polymorphism and Type 2 Diabetic Kidney Disease in Yunnan Han Population. Journal of Kunming Medical University, 2023, 44(6): 26-32. doi: 10.12259/j.issn.2095-610X.S20230621
[5]	Juli SHEN, Huifang JIA, Mei GAO, Jinmei DUAN, Ping LIU, Zuyan SUN, Huixian LIN. Application of Cluster Nursing based on Risk Assessment in Prevention of Deep Vein Thrombosis of Lower Extremity after Total Hysterectomy. Journal of Kunming Medical University, 2022, 43(2): 160-165. doi: 10.12259/j.issn.2095-610X.S20220212
[6]	Er-shu RUAN, Shuo WANG, Hui SU, Feng-qiong YIN, Zhong-yi QIAN, Jian-yu YANG. Effect of Ginsenoside Rg1 on Renal Protection in Type 2 Diabetic Rats. Journal of Kunming Medical University, 2021, 42(6): 50-55. doi: 10.12259/j.issn.2095-610X.S20210625
[7]	Qiong ZHOU, Bao-kun PENG, Xiao-chun WENG, Zhen JU, Nuo-pi-chu SUN, Zhe TANG. Clinical Characteristics of Newly Diagnosed Type 2 Diabetes Mellitus and Influencing Factors of Glycosylated Hemoglobin Among Tibetans in Deqin. Journal of Kunming Medical University, 2021, 42(8): 106-110. doi: 10.12259/j.issn.2095-610X.S20210819
[8]	Ling-ling YAN, Zhi-hong QIAN, Yue NI, Huang WU. Clinical Investigation of Vitamin D and Calcium Supplement’ Effect on the Occurrence of Cardiovascular and Cerebrovascular Diseases in POP Patients. Journal of Kunming Medical University, 2021, 42(10): 139-144. doi: 10.12259/j.issn.2095-610X.S20211036
[9]	Cheng-zhen ZHU, Xing ZHANG, Hao GUO. Advances on Complement Factor H and Cardiovascular Disease. Journal of Kunming Medical University, 2021, 42(8): 158-163. doi: 10.12259/j.issn.2095-610X.S20210828
[10]	Pei-qi CHEN, Zong-lu YANG, Ling ZHAO, Shi-gang DU, Lu YANG, Shi-yu Li, Yu-ru DAI, Ting-yu KE. Application of Thyroid Function in 10-year Cardiovascular Disease Risk Assessment of T2DM. Journal of Kunming Medical University, 2021, 42(12): 28-35. doi: 10.12259/j.issn.2095-610X.S20211215
[11]	Wang Jin Rui , Yang Ying . . Journal of Kunming Medical University, 2019, 40(04): 131-135.
[12]	Han Wen Ju , Niu Ben , Liang Yun, Duan Xiao Yan , Su Heng , Xue Yuan Ming . The Relationship between Thyroid Hormone and Purine Metabolism and Body Weight in Patients with Type II Diabetes and Normal Thyroid Function. Journal of Kunming Medical University, 2016, 37(11): 82-85.
[13]	He Jian Hui . The Distribution of Body Weight Related Index and Relationship with Cardiovascular Diseases in Rural Residents of Yunnan Province. Journal of Kunming Medical University,
[14]	Xiang Xi . . Journal of Kunming Medical University,
[15]	Wang Xiang Yun . . Journal of Kunming Medical University,
[16]	Du Juan . . Journal of Kunming Medical University,
[17]	Yang Li . . Journal of Kunming Medical University,
[18]	Wang Cun De . . Journal of Kunming Medical University,
[19]	Li Xian Li . . Journal of Kunming Medical University,
[20]	Bu Rui . Clinical Research of Vascular Endothelium Function in Type 2 Diabetes Patients with High-Frequency Color Ultrasonography. Journal of Kunming Medical University,